TOP News

World: Pfizer’s clinical data puts the US one step closer to a Covid-19 vaccine for younger kids

Fauci says people 'react against me' when 'truth becomes inconvenient'

  Fauci says people 'react against me' when 'truth becomes inconvenient' Fauci says he has been targeted by conspiracy theorists because he chooses to stand by 'science, data and hard facts. He claims people react against him when they don't like the truth.During an interview on Fox News Sunday, Fauci said: 'I have stood for always making science data and evidence, be what we guide ourselves by and I think people who feel differently, who have conspiracy theories, who deny reality, that's looking them straight in the eye.

A Food and Drug Administration review this week determined that Pfizer-BioNTech’s Covid-19 vaccine is safe and effective for children ages 5 to 11, paving the way for a shot to be authorized for that age group as soon as early November.

Third grade dual-language students wear masks on the first day of school at Montara Avenue Elementary School in Los Angeles, California, on on August 16, 2021. © Allen J. Schaben/Los Angeles Times via Getty Images Third grade dual-language students wear masks on the first day of school at Montara Avenue Elementary School in Los Angeles, California, on on August 16, 2021.

Pfizer also announced on Friday that the vaccine is more than 90 percent effective at protecting school-age children from serious illness or hospitalization from Covid-19, similar to the level of protection it provides in adults.

What If mRNA Vaccines Could Cure Cancer?

  What If mRNA Vaccines Could Cure Cancer? BioNTech’s founders preview the future of the technology that’s already (partially) saved the world.Last year, mRNA technology powered the two fastest vaccine developments in history. Moderna famously prepared its COVID-vaccine recipe in about 48 hours. And then there’s BioNTech, a German biotech firm that originally partnered with Pfizer to develop flu therapies but moved quickly to produce its own shot for the new disease. Within 24 hours of the genetic sequencing of the coronavirus, BioNTech had built eight potential vaccine candidates. The company eventually tested more than 20.

The FDA analysis looked at data from Pfizer clinical trials in four different scenarios and concluded that any risks — in particular, a vaccine-related pediatric myocarditis that typically lasts a few days — were negligible in comparison to the benefits for the age group.

Previous data from Pfizer showed that young children were able to tolerate the vaccine well and produced a strong immune response, and the results of Friday’s FDA review are further confirmation of its effectiveness.

The 2,268 children ages 5 through 11 in Pfizer’s clinical trials received doses a third the size of an adult vaccine dose, spaced 21 days apart.

Now that the initial review is complete, there are just a few steps left before Pfizer’s coronavirus vaccine can be authorized for the approximately 28 million American children ages 5 through 11.

The 90% effective pfizer vaccine from 5 to 11 years old

 The 90% effective pfizer vaccine from 5 to 11 years old © Thomas COEX An injection of the Pfizer vaccine on September 13, 2021 in Paris The CVIZ-19 vaccine is effective at 90, 7% To prevent the symptomatic forms of the disease in children aged 5 to 11, said the company on Friday, whose application for authorization for its remedy for this age group must be examined next week in the States. -United. The laboratory provided the US medicine agency (FDA) the detailed results of its clinical trials, relating to about 2,250 children aged 5 to 11.

Next week, the FDA’s panel of independent experts will examine the research and make specific recommendations to the FDA about administering the Pfizer vaccine to this age group.

Much as with recommendations about booster shots, the advisory committee is able to offer specific, granular guidance about the vaccine’s safety and necessity. For example, in September of this year, after the Biden administration had planned a widespread rollout of vaccine boosters, the FDA panel recommended that only certain populations receive an additional shot.

However, as Vox’s Dylan Scott points out, “the groups already okayed by the FDA and Centers for Disease Control and Prevention for booster shots are quite broad and cover much of the adult population.”

The FDA panel will meet Tuesday and offer FDA leadership its assessment. The FDA typically follows the advice of its expert panel, but its guidance isn’t binding.

Dr. Saphier: Children have been hurt enough by lockdowns. Think twice before mandating a vaccine for kids

  Dr. Saphier: Children have been hurt enough by lockdowns. Think twice before mandating a vaccine for kids Parents should have the option to vaccinate their children when a vaccine becomes available. This is especially true for parents of kids with pre-existing medical conditions, including obesity. As highlighted in a recent study from the Centers for Disease Control and Prevention (CDC), a real-world analysis of Covid-19 hospitalizations among adolescents aged 12–18 years showed 72 percent of those hospitalized had at least one underlying pre-existing medical condition. Of the hospitalized, 97 percent were unvaccinated, highlighting the importance of vaccinating high-risk adolescents.

If the advisory committee’s advice conforms with the agency’s initial review of the data, the FDA will likely authorize the vaccine soon after.

After that, Pfizer then must present its data to the CDC’s Advisory Committee on Immunization Practices or ACIP. It’s a similar body to the FDA’s advisory committee — a rotating, independent panel of scientists and other experts who can make specific recommendations to the CDC about administering the vaccine. That panel is scheduled to meet November 2 and 3 to discuss pediatric vaccines, according to CNN.

Then, ultimately, it’s up to CDC director Dr. Rochelle Walensky to guide the CDC’s decision on pediatric Covid-19 vaccines. As with the FDA’s advisory body, ACIP’s recommendations aren’t binding, but the CDC typically follows them.

Both bodies have to authorize the vaccine; the FDA is first and foremost concerned with the safety of anything submitted for emergency use authorization or full regulatory approval. That means asking not only whether the drug itself is safe, but also inspecting manufacturing facilities and practices while the drug in question is licensed. Meanwhile, the CDC’s concerns are geared more toward how the drug should be administered and to whom, in addition to its safety and efficacy.

Playdates are ruining all the fun

  Playdates are ruining all the fun It’s time to rethink how American children play.This is — or was — the playdate. Prior to 2020, it had become the primary mode of non-school social life for a lot of American kids, replacing the more unstructured play that many millennials and Gen X-ers remember from their childhoods. As Charis Granger-Mbugua, a Georgia mother of two, put it, “that’s how children play now.

As the White House waits for authorization, President Joe Biden announced a plan earlier this week to distribute pediatric vaccines in 25,000 pediatrician’s and primary care offices, as well as in children’s hospitals and school- and community-based clinics. The administration has already purchased enough doses to inoculate all children in this age group; the shots come in reconfigured packaging, with smaller needles for smaller arms.

“Kids have different needs than adults and our operational planning is geared to meet those specific needs, including by offering vaccinations in settings that parents and kids are familiar with and trust,” Jeff Zients, the White House’s Covid-19 response coordinator, told reporters on Wednesday.

The plan aims to avoid the bumpy, chaotic rollout adults faced earlier this year, as well as to build trust with families who may be hesitant to vaccinate their children by relying heavily on trusted sites like pediatricians offices, and messaging through schools.

Children aren’t as vulnerable to Covid-19 as adults, but they’re still testing positive

The likely authorization of Pfizer’s Covid-19 vaccine for children ages 5 through 11 stands to make schools a much safer place as Covid-19 continues to spread in the US.

Woman is REFUSED kidney transplant because she hadn't been vaccinated

  Woman is REFUSED kidney transplant because she hadn't been vaccinated A Colorado hospital is denying Leilani Lutali, 56, a kidney transplant until she gets the COVID-19 vaccine. Lutali was removed from the kidney transplant list because she's unvaccinated.Leilani Lutali, 56, from Colorado has been denied the chance to have a kidney transplant after the hospital that would have been performing the operation refused to treat her because she hadn't had the coronavirus vaccine.

Though children don’t often experience symptoms from Covid-19, as Vox’s German Lopez explained earlier this month, the combination of the delta variant and a return to classrooms last month resulted in a sharp rise in pediatric Covid-19 cases relative to earlier in the pandemic.

According to the the American Academy of Pediatrics, almost 6.2 million children have tested positive for Covid-19 since the pandemic began. In just the six weeks prior to October 14, 1.1 million children tested positive.

About 280 children under the age of 18 died of Covid-19 between January and September this year, according to Lopez.

“In this latest wave of Covid-19, particularly down south, there have been thousands of children hospitalized. And, frankly, it’s an embarrassment in a developed country to have even 100 children, like we’ve had, die of infectious disease that’s preventable,” Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said at a town hall earlier this month.

Since US school districts have implemented a patchwork quilt of vaccine and mask recommendations — with some states like Texas and Florida ignoring scientific evidence on the efficacy of masking and banning mask and vaccine mandates in school systems — both students and teachers are vulnerable to the illness.

And despite the eagerness of many children, teachers, and parents to get students back in the classroom, high infection rates across the US mean there have been some stops and starts, from quarantining exposed students to shutting down whole campuses after an outbreak. Vaccinating school children would help reduce the virus’s spread — not to mention reduce the number of disruptions to the school year.

The United States authorizes the Pfizer's Anti-Covid vaccine for 5-11 years old

 The United States authorizes the Pfizer's Anti-Covid vaccine for 5-11 years old © Copyright 2021, Obs twenty-eight million children could be affected in the country. The United States has authorized this Friday, October 29 the Pfizer-Biontech Covid-19 vaccine for the 5 to 11 years, paving the way for the imminent launch of a new step in the immunization campaign, which concerns 28 million children in the country.

Despite the upsides, however, some parents say they are still wary of vaccinating their children, or will opt not to do so. According to a September study by the Kaiser Family Foundation, only about a third of parents surveyed — 34 percent — said they would vaccinate their 5- to 11-year-olds as soon as that age group becomes eligible. Thirty-two percent said they would “wait and see” how well the vaccine works before having their child get the shot, and 24 percent said they wouldn’t have their children vaccinated at all.

More vaccines for more children are likely coming soon

The authorization of a Covid-19 vaccine for children ages 5 through 11 would mean that nearly everyone in the US is eligible for a vaccine, and drug companies are already making headway on shots for even younger children.

Pfizer, which along with BioNTech manufactures the only vaccine authorized for use in children under 18, is also performing clinical trials on children ages 2 to 5, and separate trials for children as young as six months.

Data from those trials is expected before the end of the year, according to Pfizer.

Moderna, which manufactures the other mRNA vaccine authorized for US adults, is also recruiting for its pediatric clinical trials on children ages 6 months to 11 years. The company submitted its clinical trial data on the vaccine’s effectiveness in teenagers ages 12 to 18 in June, but the FDA has pressed pause on authorizing it due to a possible elevated risk of myocarditis in young men. Health authorities in Sweden and Denmark have stopped administering Moderna vaccines to people under 18 in those countries due to this possible elevated risk.

With more authorizations on the horizon, many parents will likely be relieved to add Covid-19 shots to their kids’ vaccination schedules: As Friday’s FDA review confirmed, the vaccine is safe and effective for young children, and the Biden administration plans to make it widely available as soon as it’s authorized. And if Covid-19 is something we’ll have to live with as a society, as experts increasingly believe, then getting one step closer making the Covid-19 vaccine routine for young kids is very good news indeed.

Covid-19 vaccines for young kids are a big step toward a new normal .
5- to 11-year-olds may soon be eligible for the Pfizer/BioNTech vaccine. That could be a game changer for families and schools.The Food and Drug Administration last week authorized the two-dose Covid-19 vaccine from Pfizer/BioNTech for emergency use in children between the ages of 5 and 11. The agency concluded that the benefits of the vaccine outweigh the risks in young kids, following the findings of an advisory committee. Now advisers to the Centers for Disease Control and Prevention are meeting this week to discuss guidelines for how the shots should be administered.

See also